Cargando…
Blocking IL-1 to prevent respiratory failure in COVID-19
COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogen...
Autores principales: | van de Veerdonk, Frank L., Netea, Mihai G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411343/ https://www.ncbi.nlm.nih.gov/pubmed/32682440 http://dx.doi.org/10.1186/s13054-020-03166-0 |
Ejemplares similares
-
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
por: Slaats, Jeroen, et al.
Publicado: (2016) -
New Insights in the Immunobiology of IL-1 Family Members
por: van de Veerdonk, Frank L., et al.
Publicado: (2013) -
Rare variants increase the risk of severe COVID-19
por: van de Veerdonk, Frank L, et al.
Publicado: (2021) -
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
por: van de Veerdonk, Frank L, et al.
Publicado: (2020) -
IL-1β Processing in Host Defense: Beyond the Inflammasomes
por: Netea, Mihai G., et al.
Publicado: (2010)